Therapy response testing of breast cancer in a 3D high-throughput perfused microfluidic platform

Author(s):: Lanz, H.L.; Saleh, A.; Kramer, B.; Cairns, J.; Ng, C.P.; Yu, J.; Trietsch, S.J.; Hankemeier, T. (0000-0001-7871-2073); Joore, A.T.; Vulto, P.; Weinshilboum, R.; Wang, L.

Published: 2017
Publication type: Article / Letter to editor

Organ-on-a-chipPersonalized medicineTriple negativeP53 and BRCA1

Date issued: 2017-11-02
Language: English
Is part of: BMC Cancer (2017), Vol. 17, p. 709
hdl: 1887/58311
doi: 10.1186/s12885-017-3709-3